Correlation Between CSL and Nascent Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both CSL and Nascent Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CSL and Nascent Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CSL and Nascent Biotech, you can compare the effects of market volatilities on CSL and Nascent Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CSL with a short position of Nascent Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of CSL and Nascent Biotech.

Diversification Opportunities for CSL and Nascent Biotech

0.81
  Correlation Coefficient

Very poor diversification

The 3 months correlation between CSL and Nascent is 0.81. Overlapping area represents the amount of risk that can be diversified away by holding CSL and Nascent Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nascent Biotech and CSL is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CSL are associated (or correlated) with Nascent Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nascent Biotech has no effect on the direction of CSL i.e., CSL and Nascent Biotech go up and down completely randomly.

Pair Corralation between CSL and Nascent Biotech

Assuming the 90 days horizon CSL is expected to generate 37.68 times less return on investment than Nascent Biotech. But when comparing it to its historical volatility, CSL is 34.7 times less risky than Nascent Biotech. It trades about 0.15 of its potential returns per unit of risk. Nascent Biotech is currently generating about 0.16 of returns per unit of risk over similar time horizon. If you would invest  0.08  in Nascent Biotech on May 12, 2025 and sell it today you would earn a total of  0.12  from holding Nascent Biotech or generate 150.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy98.44%
ValuesDaily Returns

CSL  vs.  Nascent Biotech

 Performance 
       Timeline  
CSL 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in CSL are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly fragile essential indicators, CSL may actually be approaching a critical reversion point that can send shares even higher in September 2025.
Nascent Biotech 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Nascent Biotech are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of very weak forward indicators, Nascent Biotech displayed solid returns over the last few months and may actually be approaching a breakup point.

CSL and Nascent Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with CSL and Nascent Biotech

The main advantage of trading using opposite CSL and Nascent Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CSL position performs unexpectedly, Nascent Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nascent Biotech will offset losses from the drop in Nascent Biotech's long position.
The idea behind CSL and Nascent Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.

Other Complementary Tools

Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges